A new engineered insulin for diabetes patients hopes to improve the treatment as insulin is critical to maintain good health and normal blood-sugar levels (BSL), revealed a study conducted at Koch Institute. Researchers showed that their modified insulin can circulate in the bloodstream for at least 10 hours, and that it responds rapidly to changes in blood-sugar levels. This could eliminate the need for diabetic patients to repeatedly monitor their BSL and inject ...
No comments:
Post a Comment